1 period filed. Holdings below describe the selected month only.
NPORT-P · filed 2026-06-26
5 classes of this one portfolio · 0 exchange-listed
| Class ID | Symbol | Status | Security in the master | Type |
|---|---|---|---|---|
| C000014559 | FACDX | NOT_LISTED | not exchange-listed | — |
| C000014562 | FACTX | NOT_LISTED | not exchange-listed | — |
| C000014561 | FHCCX | NOT_LISTED | not exchange-listed | — |
| C000014563 | FHCIX | NOT_LISTED | not exchange-listed | — |
| C000205006 | FIKCX | NOT_LISTED | not exchange-listed | — |
N-PORT Item C.4.b
N-PORT Item C.4.a
as filed
Positions resolved to the master through ISIN, then rolled up through the taxonomy. 90.9% of reported value reaches a classification.
Percentages are of the reported value of positions above ($2.93B), not of the fund’s net assets ($2.89B). The two differ by cash, derivatives filed with no market value, and rounding.
138 positions in this filing
| Issuer↕ | In master | CUSIP / ISIN | Asset | Balance↕ | Value↕ | Weight▼ | Country |
|---|---|---|---|---|---|---|---|
| ANNEXON INC | ANNX | 03589W102 US03589W1027 | EC CORP | 750,000 NS | $4.40M | 0.152% | US |
| ALMAR BIOSCIENCES INC | ALMR | 010911105 US0109111056 | EC CORP | 168,000 NS | $4.21M | 0.146% | US |
| ELEMENT BIOSCIENCES INC ELEMENT BIOSCIENCES INC SER C PC PP | — | — — | EP CORP | 376,690 NS | $4.15M | 0.144% | US |
| SHOULDER INNOVATIONS INC | SI | 82537J108 US82537J1088 | EC CORP | 310,692 NS | $3.97M | 0.138% | US |
| ALEDADE INC ALEDADE INC SER B1 PC PP | — | — — | EP CORP | 130,618 NS | $3.81M | 0.132% | US |
| ALUMIS INC | ALMS | 022307102 US0223071020 | EC CORP | 150,700 NS | $3.72M | 0.129% | US |
| UPSTREAM BIO INC | UPB | 91678A107 US91678A1079 | EC CORP | 400,000 NS | $3.67M | 0.127% | US |
| CONTINEUM THERAPEUTICS INC CONTINEUM THERAPEUTICS INC CL A | CTNM | 21217B100 US21217B1008 | EC CORP | 280,000 NS | $3.59M | 0.124% | US |
| OUTSET MEDICAL INC | OM | 690145206 US6901452069 | EC CORP | 800,000 NS | $3.42M | 0.118% | US |
| RALLYBIO CORP CANDID THERAPEUTICS PIPE | — | — — | EC CORP | 2,403,200 NS | $3.36M | 0.117% | US |
| PARABILIS MEDICINES INC PARABILIS MEDICINES INC SER F PC PP | — | — — | EP CORP | 456,500 NS | $3.07M | 0.106% | US |
| KARDIUM INC/US KARDIUM INC US CONV 10% 12/31/2026 PP | — | — — | DBT CORP | 2,549,376.45 PA | $2.84M | 0.098% | US |
| CANDID THERAPEUTICS CANDID THERAPEUTICS INC SER B PC PP | — | — — | EP CORP | 1,956,465 NS | $2.74M | 0.095% | US |
| OCULAR THERAPEUTIX INC | OCUL | 67576A100 US67576A1007 | EC CORP | 277,371 NS | $2.60M | 0.090% | US |
| ZENAS BIOPHARMA INC ZENAS BIOPHARMA INC PIPE | — | — — | EC CORP | 122,099 NS | $2.36M | 0.082% | US |
| GALVANIZE THERAPEUTICS GALVANIZE THERAPEUTICS SER C-1 PC PERP PP | — | — — | EP CORP | 5,198,598 NS | $2.34M | 0.081% | US |
| MANUS BIO INC MANUS BIO INC SER ONE-6 PC PP | — | — — | EP CORP | 695,694 NS | $2.32M | 0.080% | US |
| GALVANIZE THERAPEUTICS GALVANIZE THERAPEUTICS SER B PC PERP PP | — | — — | EP CORP | 2,552,870 NS | $1.86M | 0.065% | US |
| ELEMENT BIOSCIENCES INC ELEMENT BIOSCIENCES INC SER D PC PP | — | — — | EP CORP | 246,623 NS | $1.82M | 0.063% | US |
| ELEMENT BIOSCIENCES INC ELEMENT BIOSCIENCES INC SER D1 PC PP | — | — — | EP CORP | 246,623 NS | $1.82M | 0.063% | US |
| PERCEPTIVE CAPITAL SOLUTIONS CORP FREENOME HOLDINGS INC PIPE | — | — — | EC CORP | 169,200 NS | $1.69M | 0.059% | KY |
| ASIMOV INC ASIMOV INC SER B PC PP | — | — — | EP CORP | 67,547 NS | $1.68M | 0.058% | US |
| WUGEN INC WUGEN INC CONV 0% 12/31/2199 P/P | — | — — | DBT CORP | 1,433,586 PA | $1.49M | 0.052% | US |
| FAHEAL THRIVE HOLDINGS LLC | — | — — | EC CORP | 327,591 NS | $1.48M | 0.051% | US |
| DMED BIOPHARMACEUTICAL CO LTD DMED BIOPHARMACEUTICAL CO LTD SER C PC PP | — | — — | EP CORP | 205,024 NS | $1.42M | 0.049% | CN |
| ALEDADE INC ALEDADE INC SER E1 PC PP | — | — — | EP CORP | 46,526 NS | $1.36M | 0.047% | US |
| KARDIUM INC/US KARDIUM INC US SRE D-7 PC PP (2ND CLOSING JUN… | — | — — | EP CORP | 2,164,613 NS | $1.17M | 0.040% | US |
| SALUDA MEDICAL INC SALUDA MEDICAL INC (2 YEAR LOCK UP) PP | — | — — | EC CORP | 215,913 NS | $932.7K AUD | 0.032% | US |
| GALVANIZE THERAPEUTICS GALVANIZE THERAPEUTICS CONV 10% 02/28/2027 P/P | — | — — | DBT CORP | 652,027.28 PA | $852.0K | 0.030% | US |
| IMMUNOME INC | IMNM | 45257U108 US45257U1088 | EC CORP | 33,871 NS | $777.0K | 0.027% | US |
| WUGEN INC WUGEN INC SER B PC PP | — | — — | EP CORP | 300,054 NS | $465.1K | 0.016% | US |
| SALUDA MEDICAL INC SALUDA MEDICAL INC CDI | — | — AU0000432114 | EC CORP | 966,580 NS | $419.4K AUD | 0.015% | US |
| CYCLERION THERAPEUTICS INC KORSANA BIOSCIENCES PIPE | — | — — | EC CORP | 138,700 NS | $337.0K | 0.012% | US |
| ELEVATEBIO, LLC ELEVATEBIO LLC SER C PC PP | — | — — | EP CORP | 163,300 NS | $300.5K | 0.010% | US |
| KARDIUM INC/US KARDIUM INC US SRE D-7 PC PP (1ST CLOSING JUN… | — | — — | EP CORP | 450,354 NS | $243.2K | 0.008% | US |
| ACUMEN PHARMACEUTICALS INC | ABOS | 00509G209 US00509G2093 | EC CORP | 84,427 NS | $201.8K | 0.007% | US |
| MEDICAL MICROINSTRUMENTS INC MEDICAL MICROINSTRUMENTS INC WT 02/16/2031 PP | — | — — | EC CORP | 9,982 NS | $108.7K | 0.004% | US |
| CYCLERION THERAPEUTICS INC | CYCN | 23255M204 US23255M2044 | EC CORP | 1,500 NS | $5.0K | 0.000% | US |